Celevity
Matthew Peloquin has a Master of Science in Molecular Neurobiology and Behavior from The University of Akron. With a Bachelor of Science in Biology from Mississippi State University, Matthew has extensive experience in research and science. Matthew has held various roles such as Head of Metabolic Science, Team Lead, Principal Scientist, and Senior Scientist in companies like Loyal / Cellular Longevity, Nemours, Pfizer, Sanford Burnham Prebys Medical Discovery Institute, and The University of Tennessee Health Science Center. Matthew has also served as a Teaching Assistant and Graduate Research Assistant at The University of Akron.
This person is not in any offices
Celevity
Celevity is a seed-stage company that develops drugs to help dogs live longer, healthier lives.